BioCentury
ARTICLE | Clinical News

Abasol abafungin regulatory update

August 1, 2005 7:00 AM UTC

York Pharma plc (LSE:YRK), Hertfordshire, U.K. Product: Abasol abafungin Business: Infectious YRK submitted an MAA in the U.K. under the mutual recognition procedure for its Abasol abafungin to treat...